Molecule Details
| InChIKey | GECBBEABIDMGGL-RTBURBONSA-N |
|---|---|
| Compound Name | Nabilone |
| Canonical SMILES | CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(=O)C[C@@H]21 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 8.7 |
| Source | BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB00486 |
|---|---|
| Drug Name | Nabilone |
| CAS Number | 51022-71-0 |
| Groups | approved investigational |
| ATC Codes | A04AD11 |
| Description | Nabilone (marketed as Cesamet) is a synthetic form of delta-9-tetrahydrocannabinol (Δ⁹-THC), the primary psychoactive component of cannabis (marijuana). Although structurally distinct from THC, nabilone mimics THC's structure and pharmacological activity through weak partial agonist activity at Cann... |
Categories: Agents producing tachycardia Alimentary Tract and Metabolism Antiemetics Antiemetics and Antinauseants Autonomic Agents Cannabinoids and similars Central Nervous System Agents Central Nervous System Depressants Cytochrome P-450 CYP2C8 Inhibitors Cytochrome P-450 CYP2C8 Inhibitors (moderate) Cytochrome P-450 CYP2C8 Substrates Cytochrome P-450 CYP2C9 Inhibitors Cytochrome P-450 CYP2C9 Inhibitors (moderate) Cytochrome P-450 CYP2C9 Substrates Cytochrome P-450 CYP2E1 Inhibitors Cytochrome P-450 CYP2E1 Inhibitors (weak) Cytochrome P-450 CYP2E1 Substrates Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (weak) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Drugs causing inadvertant photosensitivity Gastrointestinal Agents Hypotensive Agents Miscellaneous Antiemetics Peripheral Nervous System Agents Photosensitizing Agents Psychotropic Drugs Terpenes Tranquilizing Agents
Cross-references: BindingDB: 50287941 CHEMBL947 ChemSpider: 4447641 Drugs Product Database (DPD): 2071 D05099 PharmGKB: PA164746998 PubChem:5284592 PubChem:46505171 RxCUI: 31447 Therapeutic Targets Database: DAP000067 Wikipedia: Nabilone ZINC: ZINC000001542930
Target Activities (2)
DrugBank Target Actions (11)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P05181 | CYP2E1 | Cytochrome P450 2E1 | inhibitor | enzymes |
| P08684 | CYP3A4 | Cytochrome P450 3A4 | inhibitor | enzymes |
| P10632 | CYP2C8 | Cytochrome P450 2C8 | inhibitor | enzymes |
| P11712 | CYP2C9 | Cytochrome P450 2C9 | inhibitor | enzymes |
| P05181 | CYP2E1 | Cytochrome P450 2E1 | substrate | enzymes |
| P08684 | CYP3A4 | Cytochrome P450 3A4 | substrate | enzymes |
| P10632 | CYP2C8 | Cytochrome P450 2C8 | substrate | enzymes |
| P11712 | CYP2C9 | Cytochrome P450 2C9 | substrate | enzymes |
| P51589 | CYP2J2 | Cytochrome P450 2J2 | substrate | enzymes |
| P21554 | CNR1 | Cannabinoid receptor 1 | partial agonist | targets |
| P34972 | CNR2 | Cannabinoid receptor 2 | partial agonist | targets |